These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 13908637)

  • 1. [Apropos of iproniazid. Inhibition of monoamine oxidase in therapy].
    HOLZER J; SOLIGNAC H
    Prod Pharm; 1961 Oct; 16():482-4. PubMed ID: 13908637
    [No Abstract]   [Full Text] [Related]  

  • 2. Amine oxidases. XIX. Inhibition of monoamine oxidase by phenylcyclopropylamines and iproniazid.
    ZELLER EA; SARKAR S
    J Biol Chem; 1962 Jul; 237():2333-6. PubMed ID: 14010087
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of monoamine oxidase activity in sympathetic ganglia of the cat.
    LEVINE RJ
    Biochem Pharmacol; 1962; 11():395-6. PubMed ID: 14464650
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical observations on iproniazid in idiots with epilepsy.
    REBHUN J
    Calif Med; 1960 Mar; 92(3):207-9. PubMed ID: 14436745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apropos of the mechanism of action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    Experientia; 1961 Dec; 17():563-4. PubMed ID: 14473094
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
    Gomes B
    Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the inhibition of monoamine oxidase by M & B 9302 (clorgyline). II. Comparison of M & B 9302 inhibition with that of iproniazid.
    Hall DW; Logan BW
    Biochem Pharmacol; 1969 Aug; 18(8):1955-9. PubMed ID: 5811628
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple substrate determination of monoamine oxidase distribution and iproniazid inhibition in rat brain.
    La Motte RH; Schmidt DE; Ruliffson WS
    J Neurochem; 1969 May; 16(5):725-30. PubMed ID: 5770018
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 10. [THE INFLUENCE OF EPHEDRINE ON THE ACTIVITY OF AMINE OXIDASE].
    BEI MY
    Yao Xue Xue Bao; 1964 Dec; 11():834-6. PubMed ID: 14254784
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contribution to the study of attenzione in subjects subjected to thymoleptic therapy (imipramine, iproniazid, phenelzine, etryptamine)].
    MEDAGLINI E
    Riv Sper Freniatr Med Leg Alien Ment; 1962 Jun; 86():494-500. PubMed ID: 14471966
    [No Abstract]   [Full Text] [Related]  

  • 12. [INHIBITION OF MONOAMINE OXIDASE AND POTENTIATION OF EXPERIMENTAL SLEEP].
    LECHAT P; LEMEIGNAN M
    Med Exp Int J Exp Med; 1964; 10():56-66. PubMed ID: 14121410
    [No Abstract]   [Full Text] [Related]  

  • 13. MONOAMINE OXIDASE INHIBITORS. IV. SOME DIALKYLAMINOPHENYLALKYLHYDRAZINES AND RELATED COMPOUNDS.
    FINKELSTEIN J; ROMANO JA; CHIANG E; LEE J
    J Med Chem; 1963 Mar; 6():153-5. PubMed ID: 14188787
    [No Abstract]   [Full Text] [Related]  

  • 14. [ELECTROENCEPHALOGRAPHIC CONTRIBUTION TO THE STUDY OF MONOAMINE OXIDASE INHIBITING DRUGS: CHANGES INDUCED IN EXPERIMENTAL EPILEPSY IN RABBITS].
    LUCIONI R; PENATI G; INVERNIZZI G
    Riv Neurol; 1964; 34():368-74. PubMed ID: 14208879
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the in vivo inhibition of brain and liver monoamine oxidase as produced by beta-phenylisopropylhydrazine (PIH) and iproniazid.
    GOGERTY JH; HORITA A
    J Pharmacol Exp Ther; 1960 Aug; 129():357-60. PubMed ID: 13850477
    [No Abstract]   [Full Text] [Related]  

  • 16. Species differences in the cardiac effects of a monoamine oxidase inhibitor.
    GOLDBERG ND; SHIDEMAN FE
    J Pharmacol Exp Ther; 1962 May; 136():142-51. PubMed ID: 13899710
    [No Abstract]   [Full Text] [Related]  

  • 17. [INHIBITION OF RAT BRAIN MONOAMINE OXIDASES BY BETA-PHENYLISOPROPYLHYDRAZINE AND HARMALINE: HISTOCHEMICAL STUDY OF THE ACTION OF THESE INHIBITORS AND THEIR ANTAGONISM].
    BOUCHAUD C; COUTEAUX R; GAUTRON J
    C R Hebd Seances Acad Sci; 1965 Jan; 260():348-51. PubMed ID: 14305447
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the adrenergic action of iproniazid, inhibitor of monoamine oxidase].
    MEYER F
    C R Hebd Seances Acad Sci; 1961 Apr; 252():2616-8. PubMed ID: 13769974
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 20. THE ANTAGONISM OF MONOAMINE OXIDASE (MAO) INHIBITORS BY THE RED BLOOD CELL AND ITS CONSTITUENTS.
    HORITA A
    Toxicol Appl Pharmacol; 1965 Jan; 7():97-103. PubMed ID: 14256609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.